DocMorris AG (CHIX:DOCMZ) Piotroski F-Score: 4 (As of Jun. 25, 2026) — 33% Above Median


CHIX:DOCMZ DocMorris AG CHIX:DOCMZ
67 GF Score
Price CHF7.92
GF Value CHF10.54
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is DocMorris AG Piotroski F-Score?

DocMorris AG CHIX:DOCMZ -0.31% 67 Piotroski F-Score is 4 as of Jun. 25, 2026, which is 33% above its 10-year median of 3.00. GuruFocus rates CHIX:DOCMZ with a GF Score™ of 67/100 and a GF Value™ of CHF10.54 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 651 Healthcare Providers & Services companies, DocMorris AG ranks worse than 67.43% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

DocMorris AG has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for DocMorris AG's Piotroski F-Score or its related term are showing as below:

CHIX:DOCMz' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 5
Current: 4

During the past 13 years, the highest Piotroski F-Score of DocMorris AG was 5. The lowest was 1. And the median was 3.

DocMorris AG  (CHIX:DOCMz) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


DocMorris AG Piotroski F-Score Related Terms


DocMorris AG Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for DocMorris AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocMorris AG Piotroski F-Score Chart

DocMorris AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 2.00 3.00 5.00 4.00

DocMorris AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.00 0.00 4.00 0.00

DocMorris AG Piotroski F-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, DocMorris AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where DocMorris AG's Piotroski F-Score falls into.


CHIX:DOCMZ
67GF Score
DocMorris AG CHIX:DOCMZ
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was CHF-97 Mil.
Cash Flow from Operations was CHF-27 Mil.
Revenue was CHF1,017 Mil.
Gross Profit was CHF217 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was (866.423 + 778.134) / 2 = CHF822.2785 Mil.
Total Assets at the begining of this year (Dec23) was CHF866 Mil.
Long-Term Debt & Capital Lease Obligation was CHF308 Mil.
Total Current Assets was CHF214 Mil.
Total Current Liabilities was CHF116 Mil.
Net Income was CHF82 Mil.

Revenue was CHF969 Mil.
Gross Profit was CHF203 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was (1099.445 + 866.423) / 2 = CHF982.934 Mil.
Total Assets at the begining of last year (Dec22) was CHF1,099 Mil.
Long-Term Debt & Capital Lease Obligation was CHF236 Mil.
Total Current Assets was CHF294 Mil.
Total Current Liabilities was CHF180 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

DocMorris AG's current Net Income (TTM) was -97. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

DocMorris AG's current Cash Flow from Operations (TTM) was -27. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-97.253/866.423
=-0.11224656

ROA (Last Year)=Net Income/Total Assets (Dec22)
=82.28/1099.445
=0.07483776

DocMorris AG's return on assets of this year was -0.11224656. DocMorris AG's return on assets of last year was 0.07483776. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

DocMorris AG's current Net Income (TTM) was -97. DocMorris AG's current Cash Flow from Operations (TTM) was -27. ==> -27 > -97 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=307.949/822.2785
=0.37450693

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=236.272/982.934
=0.24037423

DocMorris AG's gearing of this year was 0.37450693. DocMorris AG's gearing of last year was 0.24037423. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=213.567/116.478
=1.83353938

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=293.674/180.319
=1.62863592

DocMorris AG's current ratio of this year was 1.83353938. DocMorris AG's current ratio of last year was 1.62863592. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

DocMorris AG's number of shares in issue this year was 23.949. DocMorris AG's number of shares in issue last year was 23.707. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=216.543/1017.045
=0.21291388

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=203.348/969.462
=0.20975345

DocMorris AG's gross margin of this year was 0.21291388. DocMorris AG's gross margin of last year was 0.20975345. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=1017.045/866.423
=1.17384349

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=969.462/1099.445
=0.88177399

DocMorris AG's asset turnover of this year was 1.17384349. DocMorris AG's asset turnover of last year was 0.88177399. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+1+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

DocMorris AG has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
DocMorris AG (CHIX:DOCMZ) has a Piotroski F-Score of 4 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on DocMorris AG and its competitors. This is 33% above median its historical median of 3.00. Over the past decade, DocMorris AG's Piotroski F-Score has ranged from 1.00 to 5.00. According to the industry distribution chart, DocMorris AG ranks #439 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 67.4%.
Is DocMorris AG's Piotroski F-Score too high?
DocMorris AG's current Piotroski F-Score of 4 is 33% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 5.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. DocMorris AG's value of 4 is 20% below this industry median. Based on the distribution chart, DocMorris AG ranks #439 out of 651 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DocMorris AG has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Piotroski F-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #439 out of 651 companies for Piotroski F-Score. This places DocMorris AG in the lower half of its industry. The industry median Piotroski F-Score is 5.00. DocMorris AG's value of 4 is 20% below this benchmark. Historically, DocMorris AG's own Piotroski F-Score has ranged from 1.00 to 5.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current Piotroski F-Score is 4, which is 33% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (CHIX:DOCMZ) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.54, compared to a current price of CHF7.92 — trading 24.9% below its estimated fair value. The current Piotroski F-Score is 4, which is 33% above median its 10-year median of 3.00 and 20% below the Healthcare Providers & Services industry median of 5.00. DocMorris AG's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For DocMorris AG (CHIX:DOCMZ), the current Piotroski F-Score is 4 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocMorris AG (CHIX:DOCMZ) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of CHF7.92 is trading 24.9% below its estimated GF Value™ of CHF10.54. GuruFocus considers DocMorris AG to be Modestly Undervalued.

Key valuation signals for CHIX:DOCMZ:

  • Piotroski F-Score: 4 (33% above median its 10-year median of 3.00)
  • GF Value™: CHF10.54 vs. price of CHF7.92 (24.9% below fair value)
  • GF Score™: 67/100 with 8 warning signs
  • Industry Position: 20% below the Healthcare Providers & Services median (#439 of 651)

No single metric tells the full story. See the CHIX:DOCMZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DocMorris AG Business Description

Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
67GF Score

Get the complete analysis for CHIX:DOCMZ

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF7.92
Price
CHF10.54
GF Value